Arterial hypertension has been established as a major risk factor for disease severity and mortality associated with COVID-19, while being also a predictor of poor outcomes in COVID-19 patients [23–25], probably by dysregulation of the renin–angiotensin–aldosterone system (RAAS) and the association with inflammation and immune responses [47]. Here, REN is linked to COVID-19.